Related Experiment Video

Updated: Jun 28, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

[Prader-Willi syndrome and growth hormone treatment]

F Castinetti1, R Reynaud, T Brue

  • 1Service d'Endocrinologie, Diabète et Maladies Métaboliques, Hôpital de la Timone et Centre de Référence des Maladies Rares d'origine hypophysaire, Université de la Méditerranée, Marseille, France. CastiFred@free.fr

Annales D'Endocrinologie
|October 29, 2008
PubMed

Insights

Prader Willi syndrome (PWS) is a genetic disorder affecting the hypothalamus and pituitary gland, often requiring growth hormone (GH) treatment. GH therapy can improve height and development but requires careful monitoring for potential complications like sleep apnea.

Area of Science:

  • Genetics and Endocrinology
  • Pediatric Endocrinology
  • Neuroendocrinology

Context:

  • Prader Willi syndrome (PWS) is a complex genetic disorder originating from a paternal chromosome 15 deletion.
  • It presents with significant challenges including eating disorders, obesity, and behavioral issues.
  • PWS is linked to increased morbidity and mortality, particularly from respiratory infections and cardiovascular risks.

Purpose:

  • To summarize the key aspects of Prader Willi syndrome (PWS).
  • To highlight the role of growth hormone (GH) in managing PWS.
  • To underscore the importance of monitoring potential complications associated with GH treatment.

Summary:

  • PWS is a hypothalamo-hypophyseal disorder frequently caused by a paternal chromosome 15 deletion, leading to obesity, eating disorders, and behavioral problems.
  • Growth hormone (GH) deficiency is common, and GH treatment is effective for improving height, body composition, and psychomotor development.
  • Potential risks include obstructive apnea, especially with rapid dose increases, and mortality may be influenced by corticotroph deficiency.

Impact:

  • GH treatment offers significant benefits for individuals with PWS, improving physical and developmental outcomes.
  • Understanding PWS pathophysiology and treatment nuances is crucial for mitigating associated health risks.
  • This information supports clinical management and research into optimizing PWS patient care.

More Related Videos

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...